From the Dr. Kiran C. Patel College of Osteopathic Medicine…
October 2024 Research Highlights reported by the Dr. Kiran C. Patel College of Osteopathic Medicine.
Darren Cohen, D.O., Chair, Emergency Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine
Project SEAMIST (South East Area Maritime Industry Safety Training) targets a unique worker population with both significant safety concerns, and concerns that are unique to their occupation, transport of hazardous materials with proximity to the shore of oceans and rivers. Since inception in 2011, we have trained approximately 27,500 professionals in various safety courses to improve worker safety. Project SEAMIST exists to provide ongoing health and safety training to those who work in or in concert with the maritime industry and those who may encounter hazardous materials in their normal workday.
Farzanna S. Haffizulla MD MACP FAMWA, Past Chair/Associate Professor, Department of Internal Medicine, Dr. Kiran C. Patel College of Osteopathic Medicine
The Caribbean Diaspora Health Initiatives serve as a population health platform to advance health equity and promote disease prevention in culturally meaningful and impactful ways. This initiative is all-encompassing and includes ongoing public and population health research, peer-reviewed publications, community health programs such as “In the Kitchen with Dr. H,” and a newly published patented app (M3) to facilitate the creation of diverse healthcare teams. Since 2017, this work has reached over 5 million people and has been shown to effectively promote positive lifestyle changes in underserved and under-represented communities thereby reducing the incidence of obesity, heart disease, diabetes, hypertension, stroke, and other preventable diseases.
https://www.youtube.com/@IntheKitchenWithDrH
https://nsucaribbeanhealth.com/
https://www.miamiherald.com/news/health-care/article252008388.html
Kempuraj Duraisamy, PhD, Associate Professor, Co-Director, E.M. Paper Laboratory of Clinical Immunology, Institute of Neuroimmune Medicine (INIM), Dr. Kiran C. Patel College of Osteopathic Medicine
Neurodegenerative disorders and Neurovascular pathologies – Neurovascular unit (NVU)/blood-brain barrier (BBB) regulates brain homeostasis. NVU/BBB has been affected in neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and stroke/traumatic brain injury (TBI) and increases neuroinflammation and neurodegeneration. He is currently studying NUV/BBB alterations in neuroinflammatory disorders including brain on-a-chip disease models (ME/CFS), Long COVID, open-filed blast explosion-induced TBI and other neurodegenerative disorders, brain on-a-chip disease models, and neurotherapeutics.
https://www.ncbi.nlm.nih.gov/myncbi/1n1GvvxUz6sQ0/bibliography/public/
https://scholar.google.com/citations?user=9HursUAAAAAJ&hl=en&oi=ao
https://loop.frontiersin.org/people/391552/overview
Theoharis Theoharides, MS, MPhil, PhD, MD, FAAAI, Professor, Vice Chair of Clinical Immunology, Director, Institute of Neuroimmune Medicine (INIM) – Clearwater, Dr. Kiran C. Patel College of Osteopathic Medicine
Neuroinflammatory disorders and Neurovascular Inflammation – Neuroinflammatory disorders such as Amyotrophic lateral sclerosis (ALS), mast cell activation disorders (MCADs), Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and Parkinson’s disease (PD), involve neurovascular inflammation. Mast cells are critical in allergies and inflammation and also regulate the blood-brain barrier (BBB) allowing the entry into the brain of substances that activate the brain defenders, microglia. These conditions affect multiple organ systems and are often comorbid in the same patients. As a result, diagnosis is difficult, and patients usually visit as many as ten different specialists over as many years before proper diagnosis is made. We are working to create human neuroimmune brain on-a-chip disease models using control and patient-specific hiPSC-derived cells stimulated by disease-relevant triggers for early therapeutic interventions and treatment advancement that would lead to pilot clinical trials.
https://www.mastcellmaster.com/
www.drtheoharides.com
https://pubmed.ncbi.nlm.nih.gov/?term=theoharides&sort=date